Roth, Andrew
Roth, Andrew was paid $161K by Medicaid between May 2019 and Oct 2024, across 7 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 46% of everything it billed.
LOMBARD, IL 60148
Next to other Obstetrics & Gynecology Physician providers in Illinois
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 75 | $5K | |
| 2020 | 138 | $10K | |
| 2021 | 2,677 | $100K | |
| 2022 | 20 | $2K | |
| 2023 | 51 | $4K | |
| 2024incomplete | 557 | $40K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 46% | 988 | 706 | $74K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 722 | 422 | $59K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.5% | 1,175 | 780 | $14K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 6.9% | 450 | 375 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 64 | 58 | $2K |
| 76140 | <1% | 81 | 59 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 38 | 27 | $218.12 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.